Материал: 2019 ESC - supraventricular tachycardia

ESC National Cardiac Societies actively involved in the review process of the 2019 ESC Guidelines for the management of patients with supraventricular tachycardia:

Algeria: Algerian Society of Cardiology, Walid Amara; Armenia: Armenian Cardiologists Association, Svetlana Grigoryan; Austria: Austrian Society of Cardiology, Andrea Podczeck-Schweighofer; Belarus: Belorussian Scientific Society of Cardiologists, Alexandr Chasnoits; Belgium: Belgian Society of Cardiology, Yves Vandekerckhove; Bosnia and Herzegovina: Association of Cardiologists of Bosnia and Herzegovina, Sekib Sokolovich; Bulgaria: Bulgarian Society of Cardiology, Vassil Traykov; Croatia: Croatian Cardiac Society, Bosko Skoric; Cyprus: Cyprus Society of Cardiology, Elias Papasavvas; Czech Republic: Czech Society of Cardiology, Josef Kautzner; Denmark: Danish Society of Cardiology, Sam Riahi; Estonia: Estonian Society of Cardiology, Priit Kampus; Finland: Finnish Cardiac Society, Hannu Parikka; France: French Society of Cardiology, Olivier Piot; Georgia: Georgian Society of Cardiology, Kakhaber Etsadashvili; Germany: German Cardiac Society, Christoph Stellbrink; Greece: Hellenic Society of Cardiology, Antonis S. Manolis; Hungary: Hungarian Society of Cardiology, Zoltan Csanadi; Iceland: Icelandic Society of Cardiology, Kristjan Gudmundsson; Ireland: Irish Cardiac Society, John Erwin; Israel: Israel Heart Society, Alon Barsheshet; Italy: Italian Federation of Cardiology, Roberto De Ponti; Kazakhstan: Association of Cardiologists of Kazakhstan, Ayan Abdrakhmanov; Kosovo (Republic of): Kosovo Society of Cardiology, Haki Jashari; Kyrgyzstan: Kyrgyz Society of Cardiology, Olga Lunegova; Latvia: Latvian Society of Cardiology, Kristine Jubele; Lebanon: Lebanese Society of Cardiology, Marwan M. Refaat; Lithuania: Lithuanian Society of Cardiology, Aras Puodziukynas; Luxembourg: Luxembourg Society of Cardiology, Laurent Groben; Moldova (Republic of): Moldavian Society of Cardiology, Aurel Grosu; Montenegro: Montenegro Society of Cardiology, Nikola Pavlovic; Morocco: Moroccan Society of Cardiology, Fellat Ibtissam; Netherlands: Netherlands Society of Cardiology, Serge A. Trines; North Macedonia: North Macedonian Society of Cardiology, Lidija Poposka; Norway: Norwegian Society of Cardiology, Kristina H. Haugaa; Poland: Polish Cardiac Society, Oskar Kowalski; Portugal: Portuguese Society of Cardiology, Diogo Cavaco; Romania: Romanian Society of Cardiology, Dan Dobreanu; Russian Federation: Russian Society of Cardiology, Evgeny N. Mikhaylov; San Marino: San Marino Society of Cardiology, Marco Zavatta; Serbia: Cardiology Society of Serbia, Mujovic Nebojsa; Slovakia: Slovak Society of Cardiology, Peter Hlivak; Spain: Spanish Society of Cardiology, Ignacio Ferreira-Gonzalez; Sweden: Swedish Society of Cardiology, Tord Juhlin; Switzerland: Swiss Society of Cardiology, Tobias Reichlin; Tunisia: Tunisian Society of Cardiology and Cardio-Vascular Surgery, Habib Haouala; Turkey: Turkish Society of Cardiology, Taylan Akgun; United Kingdom of Great Britain and Northern Ireland: British Cardiovascular Society, Dhiraj Gupta.

24 References

1.Blomstro¨m-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, Campbell WB, Haines DE, Kuck KH, Lerman BB, Miller DD, Shaeffer CW, Stevenson WG, Tomaselli GF. ACC/AHA/ESC guidelines for the management of

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

patients with supraventricular arrhythmias–executive summary: a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. J Am Coll Cardiol 2003;42:1493 1531.

2.Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ, Estes NAM, Field ME, Goldberger ZD, Hammill SC, Indik JH, Lindsay BD, Olshansky B, Russo AM, Shen W-K, Tracy CM, Al-Khatib SM. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2016;67:1575 1623.

3.Katritsis DG, Boriani G, Cosio FG, Hindricks G, Jais P, Josephson ME, Keegan R, Kim Y-H, Knight BP, Kuck K-H, Lane DA, Lip GYH, Malmborg H, Oral H, Pappone C, Themistoclakis S, Wood KA, Blomstro¨m-Lundqvist C. European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), AsiaPacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE). Eur Heart J 2018;39:1442 1445.

4.Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener H-C, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P, Agewall S, Camm J, Baron Esquivias G, Budts W, Carerj S, Casselman F, Coca A, De Caterina R, Deftereos S, Dobrev D, Ferro JM, Filippatos G, Fitzsimons D, Gorenek B, Guenoun M, Hohnloser SH, Kolh P, Lip GYH, Manolis A, McMurray J, Ponikowski P, Rosenhek R, Ruschitzka F, Savelieva I, Sharma S, Suwalski P, Tamargo JL, Taylor CJ, Van Gelder IC, Voors AA, Windecker S, Zamorano JL, Zeppenfeld K. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016;37:2893 2962.

5.Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, Chen PS, Chen SA, Chung MK, Nielsen JC, Curtis AB, Davies DW, Day JD, d’Avila A, de Groot N, Di Biase L, Duytschaever M, Edgerton JR, Ellenbogen KA, Ellinor PT, Ernst S, Fenelon G, Gerstenfeld EP, Haines DE, Haissaguerre M, Helm RH, Hylek E, Jackman WM, Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH, Kumagai K, Lee R, Lewalter T, Lindsay BD, Macle L, Mansour M, Marchlinski FE, Michaud GF, Nakagawa H, Natale A, Nattel S, Okumura K, Packer D, Pokushalov E, Reynolds MR, Sanders P, Scanavacca M, Schilling R, Tondo C, Tsao HM, Verma A, Wilber DJ, Yamane T. 2017 HRS/ EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary. Europace 2018;20:157 208.

6.Mairesse GH, Moran P, Van Gelder IC, Elsner C, Rosenqvist M, Mant J, Banerjee A, Gorenek B, Brachmann J, Varma N, Glotz de Lima G, Kalman J, Claes N, Lobban T, Lane D, Lip GYH, Boriani G; ESC Scientific Document Group. Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE). Europace 2017;19:1589 1623.

7.Lip GYH, Collet JP, Haude M, Huber K. Management of antithrombotic therapy in AF patients presenting with ACS and/or undergoing PCI: a summary of the Joint Consensus Document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). Eur Heart J 2018;39:2847 2850.

8.Wit AL, Wellens HJ, Josephson ME. Electrophysiological foundations of cardiac arrhythmias. 1st ed. Minneapolis: Cardiotext Publishing; 2017.

9.Orejarena LA, Vidaillet H, DeStefano F, Nordstrom DL, Vierkant RA, Smith PN, Hayes JJ. Paroxysmal supraventricular tachycardia in the general population. J Am Coll Cardiol 1998;31:150 157.

10.Wu M-H, Chen H-C, Kao F-Y, Huang S-K. Postnatal cumulative incidence of supraventricular tachycardia in a general pediatric population: a national birth cohort database study. Heart Rhythm 2016;13:2070 2075.

11.Garcıa-Fernandez FJ, Iba~nez Criado JL, Quesada Dorador A; collaborators of the Spanish Catheter Ablation Registry; REGISTRY COLLABORATORS. Spanish Catheter Ablation Registry. 17th Official Report of the Spanish Society of Cardiology Working Group on Electrophysiology and Arrhythmias (2017). Rev Esp Cardiol (Engl Ed) 2018;71:941 951.

12.Hosseini SM, Rozen G, Saleh A, Vaid J, Biton Y, Moazzami K, Heist EK, Mansour MC, Kaadan MI, Vangel M, Ruskin JN. Catheter ablation for cardiac arrhythmias: utilization and in-hospital complications, 2000 to 2013. JACC Clin Electrophysiol 2017;3:1240 1248.

13.Holmqvist F, Kesek M, Englund A, Blomstro¨m-Lundqvist C, Karlsson LO, Kenneb€ack G, Poc¸i D, Samo-Ayou R, Sigurjonsdottir R, Ringborn M, Herczku C, Carlson J, Fengsrud E, Tabrizi F, Ho¨glund N, Lo¨nnerholm S, Kongstad O, Jo¨nsson A, Insulander P. A decade of catheter ablation of cardiac arrhythmias in Sweden: ablation practices and outcomes. Eur Heart J 2019;40:820 830.

14.Porter MJ, Morton JB, Denman R, Lin AC, Tierney S, Santucci PA, Cai JJ, Madsen N, Wilber DJ. Influence of age and gender on the mechanism of supraventricular tachycardia. Heart Rhythm 2004;1:393 396.

15.Gonzalez-Torrecilla E, Almendral J, Arenal A, Atienza F, Atea LF, del Castillo S, Fernandez-Aviles F. Combined evaluation of bedside clinical variables and the electrocardiogram for the differential diagnosis of paroxysmal atrioventricular reciprocating tachycardias in patients without pre-excitation. J Am Coll Cardiol 2009;53:2353 2358.

16.Liuba I, Jo¨nsson A, S€afstro¨m K, Walfridsson H. Gender-related differences in patients with atrioventricular nodal reentry tachycardia. Am J Cardiol 2006;97:384 388.

17.Rosano GMC, Leonardo F, Rosano GMC, De Luca F, Sarrel PM, Beale CM, Collins P. Cyclical variation in paroxysmal supraventricular tachycardia in women. Lancet 1996;347:786 788.

18.Chang S-H, Kuo C-F, Chou I-J, See L-C, Yu K-H, Luo S-F, Chiou M-J, Zhang W, Doherty M, Wen M-S, Chen W-J, Yeh Y-H. Outcomes associated with paroxysmal supraventricular tachycardia during pregnancy. Circulation 2017;135:616 618.

19.Krahn AD, Manfreda J, Tate RB, Mathewson FL, Cuddy T. The natural history of electrocardiographic preexcitation in men: the Manitoba Follow-up Study. Ann Intern Med 1992;116:456 460.

20.Vidaillet HJJ, Pressley JC, Henke E, Harrell FEJ, German LD. Familial occurrence of accessory atrioventricular pathways (preexcitation syndrome). N Engl J Med 1987;317:65 69.

21.Lu C-W, Wu M-H, Chen H-C, Kao F-Y, Huang S-K. Epidemiological profile of Wolff Parkinson White syndrome in a general population younger than 50 years of age in an era of radiofrequency catheter ablation. Int J Cardiol 2014;174:530 534.

22.Skov MW, Rasmussen PV, Ghouse J, Hansen SM, Graff C, Olesen MS, Pietersen A, Torp-Pedersen C, Haunsø S, Køber L, Svendsen JH, Holst AG, Nielsen JB. Electrocardiographic preexcitation and risk of cardiovascular morbidity and mortality. Results from the Copenhagen ECG Study. Circ Arrhythm Electrophysiol 2017;10:e004778.

23.Granada J, Uribe W, Chyou P-H, Maassen K, Vierkant R, Smith PN, Hayes J, Eaker E, Vidaillet H. Incidence and predictors of atrial flutter in the general population. J Am Coll Cardiol 2000;36:2242 2246.

24.Withers KL, White J, Carolan-Rees G, Patrick H, O’Callaghan P, Murray S, Cunningham D, Wood KA, Lencioni M, Griffith M. Patient reported outcome measures for cardiac ablation procedures: a multicentre pilot to develop a new questionnaire. Europace 2014;16:1626 1633.

25.Wood KA, Stewart AL, Drew BJ, Scheinman MM, Froelicher ES. Patient perception of symptoms and quality of life following ablation in patients with supraventricular tachycardia. Heart Lung 2010;39:12 20.

26.White J, Withers KL, Lencioni M, Carolan-Rees G, Wilkes AR, Wood KA, Patrick H, Cunningham D, Griffith M. Cardiff cardiac ablation patient-reported outcome measure (C-CAP): validation of a new questionnaire set for patients undergoing catheter ablation for cardiac arrhythmias in the UK. Qual Life Res 2016;25:1571 1583.

27.Brachmann J, Lewalter T, Kuck KH, Andresen D, Willems S, Spitzer SG, Straube F, Schumacher B, Eckardt L, Danilovic D, Thomas D, Hochadel M, Senges J. Long-term symptom improvement and patient satisfaction following catheter ablation of supraventricular tachycardia: insights from the German ablation registry. Eur Heart J 2017;38:1317 1326.

28.Farkowski MM, Pytkowski M, Maciag A, Golicki D, Wood KA, Kowalik I, Kuteszko R, Szwed H. Gender-related differences in outcomes and resource utilization in patients undergoing radiofrequency ablation of supraventricular tachycardia: results from Patients’ Perspective on Radiofrequency Catheter Ablation of AVRT and AVNRT Study. Europace 2014;16:1821 1827.

29.Feldman A, Voskoboinik A, Kumar S, Spence S, Morton JB, Kistler PM, Sparks PB, Vohra JK, Kalman JM. Predictors of acute and long-term success of slow pathway ablation for atrioventricular nodal reentrant tachycardia: a single center series of 1,419 consecutive patients. Pacing Clin Electrophysiol 2011;34:927 933.

30.Zimetbaum P, Josephson ME. Evaluation of patients with palpitations. N Engl J Med 1998;338:1369 1373.

31.Page RL, Wilkinson WE, Clair WK, McCarthy EA, Pritchett EL. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 1994;89:224 227.

32.Thavendiranathan P, Bagai A, Khoo C, Dorian P, Choudhry NK. Does this patient with palpitations have a cardiac arrhythmia? JAMA 2009;302:2135 2143.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

33.Leitch JW, Klein GJ, Yee R, Leather RA, Kim YH. Syncope associated with supraventricular tachycardia. An expression of tachycardia rate or vasomotor response? Circulation 1992;85:1064 1071.

34.Thiruganasambandamoorthy V, Rowe BH, Sivilotti MLA, McRae AD, Arcot K, Nemnom MJ, Huang L, Mukarram M, Krahn AD, Wells GA, Taljaard M. Duration of electrocardiographic monitoring of emergency department patients with syncope. Circulation 2019;139:1396 1406.

35.Razavi M, Luria DM, Jahangir A, Hodge DO, Low PA, Shen W-K. Acute blood pressure changes after the onset of atrioventricular nodal reentrant tachycardia: a time-course analysis. J Cardiovasc Electrophysiol 2005;16:1037 1040.

36.Abe H, Nagatomo T, Kobayashi H, Miura Y, Araki M, Kuroiwa A, Nakashima Y. Neurohumoral and hemodynamic mechanisms of diuresis during atrioventricular nodal reentrant tachycardia. Pacing Clin Electrophysiol 1997;20(11):2783-2788.

37.Chinen S, Miura M, Tamame T, Matsuoka M, Ohki H, Sumitomo N. Life-threat- ening atrial tachycardia after the Senning operation in a patient with transposition of the great arteries. Heart Vessels 2012;27:424 427.

38.Gu¨rsoy S, Steurer G, Brugada J, Andries E, Brugada P. The hemodynamic mechanism of pounding in the neck in atrioventricular nodal reentrant tachycardia. N Engl J Med 1992;327:772 774.

39.Contreras-Valdes FM, Josephson ME. IMAGES IN CLINICAL MEDICINE. “Frog sign” in atrioventricular nodal reentrant tachycardia. N Engl J Med 2016;374:e17.

40.Lessmeier TJ, Gamperling D, Johnson-Liddon V, Fromm BS, Steinman RT, Meissner MD, Lehmann MH. Unrecognized paroxysmal supraventricular tachycardia: potential for misdiagnosis as panic disorder. Arch Intern Med 1997;157:537 543.

41.Appelboam A, Reuben A, Mann C, Gagg J, Ewings P, Barton A, Lobban T, Dayer M, Vickery J, Benger J. Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): a randomised controlled trial. Lancet 2015;386:1747 1753.

42.Wang R, Blackburn G, Desai M, Phelan D, Gillinov L, Houghtaling P, Gillinov M. Accuracy of wrist-worn heart rate monitors. JAMA Cardiol 2017;2:104 106.

43.Katritsis DG, Mark DB, Gersh BJ. Revascularization in stable coronary disease: evidence and uncertainties. Nat Rev Cardiol 2018;15:408 419.

44.Michowitz Y, Tovia-Brodie O, Heusler I, Sabbag A, Rahkovich M, Shmueli H, Glick A, Belhassen B. Differentiating the QRS morphology of posterior fascicular ventricular tachycardia from right bundle branch block and left anterior hemiblock aberrancy. Circ Arrhythm Electrophysiol 2017;10:e005074.

45.Katritsis DG, Josephson ME. Differential diagnosis of regular, narrow-QRS tachycardias. Heart Rhythm 2015;12:1667 1676.

46.Roberts-Thomson KC, Kistler PM, Kalman JM. Focal atrial tachycardia I: clinical features, diagnosis, mechanisms, and anatomic location. Pacing Clin Electrophysiol 2006;29:643 652.

47.Katritsis DG, Becker A. The atrioventricular nodal reentrant tachycardia circuit: a proposal. Heart Rhythm 2007;4:1354 1360.

48.Jaı¨s P, Matsuo S, Knecht S, Weerasooriya R, Hocini M, Sacher F, Wright M, Nault I, Lellouche N, Klein G, Cle´menty J, Haı¨ssaguerre M. A deductive mapping strategy for atrial tachycardia following atrial fibrillation ablation: importance of localized reentry. J Cardiovasc Electrophysiol 2009;20:480 491.

49.Green M, Heddle B, Dassen W, Wehr M, Abdollah H, Brugada P, Wellens HJ. Value of QRS alteration in determining the site of origin of narrow QRS supraventricular tachycardia. Circulation 1983;68:368 373.

50.Chen SA, Tai CT, Chiang CE, Chang MS. Role of the surface electrocardiogram in the diagnosis of patients with supraventricular tachycardia. Cardiol Clin 1997;15:539 565.

51.Morady F. Significance of QRS alternans during narrow QRS tachycardias. Pacing Clin Electrophysiol 1991;14:2193 2198.

52.Crawford TC, Mukerji S, Good E, Chugh A, Bogun F, Pelosi F, Oral H, Morady F, Jongnarangsin K. Utility of atrial and ventricular cycle length variability in determining the mechanism of paroxysmal supraventricular tachycardia. J Cardiovasc Electrophysiol 2007;18:698 703.

53.Bogossian H, Ninios I, Frommeyer G, Bandorski D, Eckardt L, Lemke B, Zarse M. U wave during supraventricular tachycardia: simulation of a long RP tachycardia and hiding the common type AVNRT. Ann Noninvasive Electrocardiol 2015;20:292 295.

54.Nagashima K, Watanabe I, Okumura Y, Kaneko Y, Sonoda K, Kogawa R, Sasaki N, Iso K, Takahashi K, Kurokawa S, Nakai T, Ohkubo K, Hirayama A. Ventriculoatrial intervals <70 ms in orthodromic atrioventricular reciprocating tachycardia. Pacing Clin Electrophysiol 2016;39:1108 1115.

55.Letsas KP, Weber R, Herrera Siklody C, Mihas CC, Stockinger J, Blum T, Kalusche D, Arentz T. Electrocardiographic differentiation of common type atrioventricular nodal reentrant tachycardia from atrioventricular reciprocating tachycardia via a concealed accessory pathway. Acta Cardiologica 2010;65:171 176.

56.Kalbfleisch SJ, el-Atassi R, Calkins H, Langberg JJ, Morady F. Differentiation of paroxysmal narrow QRS complex tachycardias using the 12-lead electrocardiogram. J Am Coll Cardiol 1993;21:85 89.

57.Tai CT, Chen SA, Chiang CE, Lee SH, Wen ZC, Chiou CW, Ueng KC, Chen YJ, Yu WC, Chang MS. A new electrocardiographic algorithm using retrograde P waves for differentiating atrioventricular node reentrant tachycardia from atrioventricular reciprocating tachycardia mediated by concealed accessory pathway.

J Am Coll Cardiol 1997;29:394 402.

58.Di Toro D, Hadid C, Lopez C, Fuselli J, Luis V, Labadet C. Utility of the aVL lead in the electrocardiographic diagnosis of atrioventricular node re-entrant tachycardia. Europace 2009;11:944 948.

59.Haghjoo M, Bahramali E, Sharifkazemi M, Shahrzad S, Peighambari M. Value of the aVR lead in differential diagnosis of atrioventricular nodal reentrant tachycardia. Europace 2012;14:1624 1628.

60.Knight BP, Ebinger M, Oral H, Kim MH, Sticherling C, Pelosi F, Michaud GF, Strickberger SA, Morady F. Diagnostic value of tachycardia features and pacing maneuvers during paroxysmal supraventricular tachycardia. J Am Coll Cardiol 2000;36:574 582.

61.Markowitz SM, Stein KM, Mittal S, Slotwtner DJ, Lerman BB. Differential effects of adenosine on focal and macroreentrant atrial tachycardia. J Cardiovasc Electrophysiol 1999;10:489 502.

62.Alzand BSN, Manusama R, Gorgels APM, Wellens HJJ. An “almost wide” QRS tachycardia. Circ Arrhythm Electrophysiol 2009;2:e1 e3.

63.Alzand BSN, Crijns HJ. Diagnostic criteria of broad QRS complex tachycardia: decades of evolution. Europace 2011;13:465 472.

64.Stewart RB, Bardy GH, Greene H. Wide complex tachycardia: misdiagnosis and outcome after emergent therapy. Ann Intern Med 1986;104:766 771.

65.Wellens HJJ. Ventricular tachycardia: diagnosis of broad QRS complex tachycardia. Heart 2001;86:579 585.

66.Willems S, Shenasa M, Borggrefe M, Hindricks G, Chen X, Rotman B, Kottkamp H, Haverkamp W, Breithardt G. Atrioventricular nodal reentry tachycardia: electrophysiologic comparisons in patients with and without 2:1 infra-His block. Clin Cardiol 1993;16:883 888.

67.Ranger S, Talajic M, Lemery R, Roy D, Villemaire C, Nattel S. Kinetics of usedependent ventricular conduction slowing by antiarrhythmic drugs in humans. Circulation 1991;83:1987 1994.

68.Jastrzebski M, Kukla P, Czarnecka D, Kawecka-Jaszcz K. Comparison of five electrocardiographic methods for differentiation of wide QRS-complex tachycardias. Europace 2012;14:1165 1171.

69.Brugada P, Brugada J, Mont L, Smeets J, Andries EW. A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex. Circulation 1991;83:1649 1659.

70.Kindwall KE, Brown J, Josephson ME. Electrocardiographic criteria for ventricular tachycardia in wide complex left bundle branch block morphology tachycardias. Am J Cardiol 1988;61:1279 1283.

71.Vereckei A, Duray G, Sze´nasi G, Altemose GT, Miller JM. New algorithm using only lead aVR for differential diagnosis of wide QRS complex tachycardia. Heart Rhythm 2008;5:89 98.

72.Pava LF, Perafan P, Badiel M, Arango JJ, Mont L, Morillo CA, Brugada J. R-wave peak time at DII: a new criterion for differentiating between wide complex QRS tachycardias. Heart Rhythm 2010;7:922 926.

73.Steurer G, Gursoy S, Frey B, Simonis F, Andries E, Kuck K, Brugada P. The differential diagnosis on the electrocardiogram between ventricular tachycardia and preexcited tachycardia. Clin Cardiol 1994;17:306 308.

74.Jastrzebski M, Moskal P, Kukla P, Fijorek K, Kisiel R, Czarnecka D. Specificity of wide QRS complex tachycardia criteria and algorithms in patients with ventricular preexcitation. Ann Noninvasive Electrocardiol 2018;23:e12493.

75.Alberca T, Almendral J, Sanz P, Almazan A, Cantalapiedra JL, Delcan JL. Evaluation of the specificity of morphological electrocardiographic criteria for the differential diagnosis of wide QRS complex tachycardia in patients with intraventricular conduction defects. Circulation 1997;96:3527 3533.

76.Ceresnak SR, Liberman L, Avasarala K, Tanel R, Motonaga KS, Dubin AM. Are wide complex tachycardia algorithms applicable in children and patients with congenital heart disease? J Electrocardiol 2010;43:694 700.

77.Jastrzebski M, Kukla P, Czarnecka D, Kawecka-Jaszcz K. Specificity of the wide QRS complex tachycardia algorithms in recipients of cardiac resynchronization therapy. J Electrocardiol 2012;45:319 326.

78.Lau EW, Ng GA. Comparison of the performance of three diagnostic algorithms for regular broad complex tachycardia in practical application. Pacing Clin Electrophysiol 2002;25:822 827.

79.Isenhour JL, Craig S, Gibbs M, Littmann L, Rose G, Risch R. Wide-complex tachycardia: continued evaluation of diagnostic criteria. Acad Emerg Med 2000;7:769 773.

80.Baxi RP, Hart KW, Vereckei A, Miller J, Chung S, Chang W, Gottesman B, Hunt M, Culyer G, Trimarco T, Willoughby C, Suarez G, Lindsell CJ, Collins SP. Vereckei criteria as a diagnostic tool amongst emergency medicine residents to

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

distinguish between ventricular tachycardia and supra-ventricular tachycardia with aberrancy. J Cardiol 2012;59:307 312.

81.Jastrzebski M, Sasaki K, Kukla P, Fijorek K, Stec S, Czarnecka D. The ventricular tachycardia score: a novel approach to electrocardiographic diagnosis of ventricular tachycardia. Europace 2016;18:578 584.

82.Yadav AV, Nazer B, Drew BJ, Miller JM, El Masry H, Groh WJ, Natale A, Marrouche N, Badhwar N, Yang Y, Scheinman MM. Utility of conventional electrocardiographic criteria in patients with idiopathic ventricular tachycardia. JACC Clin Electrophysiol 2017;3:669 677.

83.Knight BP, Zivin A, Souza J, Goyal R, Man KC, Strickberger A, Morady F. Use of adenosine in patients hospitalized in a university medical center. Am J Med 1998;105:275 280.

84.Jolobe OMP. Caveats in preexcitation-related atrial fibrillation. Am J Emerg Med 2010;28:252 253.

85.Murman DH, McDonald AJ, Pelletier AJ, Camargo CA. U.S. Emergency Department Visits for Supraventricular Tachycardia, 1993 2003. Acad Emerg Med 2007;14(6):578-581.

86.Roth A, Elkayam I, Shapira I, Sander J, Malov N, Kehati M, Golovner M. Effectiveness of prehospital synchronous direct-current cardioversion for supraventricular tachyarrhythmias causing unstable hemodynamic states. Am J Cardiol 2003;91:489 491.

87.Wittwer MR, Rajendran S, Kealley J, Arstall MA. A South Australian registry of biphasic cardioversions of atrial arrhythmias: efficacy and predictors of success.

Heart Lung Circ 2015;24:342 347.

88.Reisinger J, Gstrein C, Winter T, Zeindlhofer E, Ho¨llinger K, Mori M, Schiller A, Winter A, Geiger H, Siostrzonek P. Optimization of initial energy for cardioversion of atrial tachyarrhythmias with biphasic shocks. Am J Emerg Med 2010;28:159 165.

89.Smith GD, Fry MM, Taylor D, Morgans A, Cantwell K. Effectiveness of the Valsalva Manoeuvre for reversion of supraventricular tachycardia. Cochrane Database Syst Rev 2015;2:CD009502.

90.Lim SH, Anantharaman V, Teo WS, Goh PP, Tan ATH. Comparison of treatment of supraventricular tachycardia by Valsalva maneuver and carotid sinus massage.

Ann Emerg Med 1998;31:30 35.

91.Smith G, Morgans A, Boyle M. Use of the Valsalva manoeuvre in the prehospital setting: a review of the literature. Emerg Med J 2009;26:8 10.

92.Brady WJJ, DeBehnke DJ, Wickman LL, Lindbeck G. Treatment of out-of-hospital supraventricular tachycardia: adenosine vs verapamil. Acad Emerg Med 1996;3(6):574-585.

93.Glatter KA, Cheng J, Dorostkar P, Modin G, Talwar S, Al-Nimri M, Lee RJ, Saxon LA, Lesh MD, Scheinman MM. Electrophysiologic effects of adenosine in patients with supraventricular tachycardia. Circulation 1999;99:1034 1040.

94.Delaney B, Loy J, Kelly A-M. The relative efficacy of adenosine versus verapamil for the treatment of stable paroxysmal supraventricular tachycardia in adults: a meta-analysis. Eur J Emerg Med 2011;18:148 152.

95.Dougherty AH, Jackman WM, Naccarelli GV, Friday KJ, Dias VC. Acute conversion of paroxysmal supraventricular tachycardia with intravenous diltiazem. Am J Cardiol 1992;70:587 592.

96.Hood MA, Smith WM. Adenosine versus verapamil in the treatment of supraventricular tachycardia: A randomized double-crossover trial. Am Heart J 1992;123:1543 1549.

97.Gupta A, Naik A, Vora A, Lokhandwala Y. Comparison of efficacy of intravenous diltiazem and esmolol in terminating supraventricular tachycardia. J Assoc Physicians India 1999;47:969 972.

98.Lim SH, Anantharaman V, Teo WS, Chan YH. Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia. Resuscitation 2009;80:523 528.

99.Das G, Tschida V, Gray R, Dhurandhar R, Lester R, McGrew F, Askenazi J, Kaplan K, Emanuele M, Turlapaty P, Hua TA, Hoff J, Allin D, Laddu A. Efficacy of esmolol in the treatment and transfer of patients with supraventricular tachyarrhythmias to alternate oral antiarrhythmic agents. J Clin Pharmacol 1988;28:746 750.

100.Amsterdam EA, Kulcyski J, Ridgeway MG. Efficacy of cardioselective beta-adre- nergic blockade with intravenously administered metoprolol in the treatment of supraventricular tachyarrhythmias. J Clin Pharmacol 1991;31:714 718.

101.Smith G, Taylor DM, Morgans A, Cameron P. Prehospital synchronized electrical cardioversion of a poorly perfused SVT patient by paramedics. Prehosp Disaster Med 2013;28:301 304.

102.Wen Z-C, Chen S-A, Tai C-T, Chiang C-E, Chiou C-W, Chang M-S. Electrophysiological mechanisms and determinants of vagal maneuvers for termination of paroxysmal supraventricular tachycardia. Circulation 1998;98:2716 2723.

103.Taylor DM, Wong LF. Incorrect instruction in the use of the Valsalva manoeuvre for paroxysmal supra-ventricular tachycardia is common. Emergency Medicine 2004;16(4):284-287.

104.Smith G, Boyle MJ. The 10 mL syringe is useful in generating the recommended standard of 40 mmHg intrathoracic pressure for the Valsalva manoeuvre. Emerg Med Australas 2009;21:449 454.

105.Layland J, Carrick D, Lee M, Oldroyd K, Berry C. Adenosine: physiology, pharmacology, and clinical applications. JACC Cardiovasc Interv 2014;7:581 591.

106.Lerman BB, Markowitz SM, Cheung JW, Liu CF, Thomas G, Ip JE. Supraventricular tachycardia. Circ Arrhythm Electrophysiol 2018;11:e006953.

107.Camm AJ, Garratt CJ. Adenosine and supraventricular tachycardia. N Engl J Med 1991;325:1621 1629.

108.Ng GA, Martin W, Rankin AC. Imaging of adenosine bolus transit following intravenous administration: insights into antiarrhythmic efficacy. Heart 1999;82:163 169.

109.Alabed S, Sabouni A, Providencia R, Atallah E, Qintar M, Chico TJA. Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia.

Cochrane Database Syst Rev 2017;10:CD005154.

110.Cabalag MS, Taylor DM, Knott JC, Buntine P, Smit D, Meyer A. Recent caffeine ingestion reduces adenosine efficacy in the treatment of paroxysmal supraventricular tachycardia. Acad Emerg Med 2010;17:44 49.

111.Karydes HC, Bryant SM. Adenosine and caffeine-induced paroxysmal supraventricular tachycardia. Acad Emerg Med 2010;17:570 570.

112.Burki NK, Wheeler JD, Lu-Yuan L. Intravenous adenosine and dyspnea in humans. J Appl Physiol (1985) 2005;98:180 185.

113.Fragakis N, Antoniadis AP, Korantzopoulos P, Kyriakou P, Koskinas KC, Geleris P. Sinus nodal response to adenosine relates to the severity of sinus node dysfunction. Europace 2012;14:859 864.

114.Ellenbogen KA, Thames MD, DiMarco JP, Sheehan H, Lerman BB. Electrophysiological effects of adenosine in the transplanted human heart. Evidence of supersensitivity. Circulation 1990;81:821 828.

115.Toft J, Mortensen J, Hesse B. Risk of atrioventricular block during adenosine pharmacologic stress testing in heart transplant recipients. Am J Cardiol 1998;82:696 697.

116.Flyer JN, Zuckerman WA, Richmond ME, Anderson BR, Mendelsberg TG, McAllister JM, Liberman L, Addonizio LJ, Silver ES. Prospective study of adenosine on atrioventricular nodal conduction in pediatric and young adult patients after heart transplantation. Circulation 2017;135:2485 2493.

117.Ip JE, Cheung JW, Chung JH, Liu CF, Thomas G, Markowitz SM, Lerman BB. Adenosine-induced atrial fibrillation. Insights into mechanism. Circ Arrhythm Electrophysiol 2013;6:e34 e37.

118.Li N, Csepe TA, Hansen BJ, Sul LV, Kalyanasundaram A, Zakharkin SO, Zhao J, Guha A, Van Wagoner DR, Kilic A, Mohler PJ, Janssen PML, Biesiadecki BJ, Hummel JD, Weiss R, Fedorov VV. adenosine-induced atrial fibrillation. Localized reentrant drivers in lateral right atria due to heterogeneous expression of adenosine A1 receptors and GIRK4 subunits in the human heart. Circulation 2016;134:486 498.

119.Turley AJ, Murray S, Thambyrajah J. Pre-excited atrial fibrillation triggered by intravenous adenosine: a commonly used drug with potentially life-threatening adverse effects. Emerg Med J 2008;25:46 48.

120.Garratt CJ, Griffith MJ, O’Nunain S, Ward DE, Camm AJ. Effects of intravenous adenosine on antegrade refractoriness of accessory atrioventricular connections. Circulation 1991;84:1962 1968.

121.Coli S, Mantovani F, Ferro J, Gonzi G, Zardini M, Ardissino D. Adenosineinduced severe bronchospasm in a patient without pulmonary disease. Am J Emerg Med 2012;30:2082.e3 2082.e5.

122.Cerqueira MD, Verani MS, Schwaiger M, Heo J, Iskandrian AS. Safety profile of adenosine stress perfusion imaging: results from the adenoscan multicenter trial registry. J Am Coll Cardiol 1994;23:384 389.

123.Balan KK, Critchley M. Is the dyspnea during adenosine cardiac stress test caused by bronchospasm? Am Heart J 2001;142:142 145.

124.Cushley MJ, Tattersfield AE, Holgate ST. Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Clin Pharmacol 2004;58:S751 S755.

125.Burki NK, Alam M, Lee L-Y. The pulmonary effects of intravenous adenosine in asthmatic subjects. Respiratory Research 2006;7:139 139.

126.Burkhart KK. Respiratory failure following adenosine administration. Am J Emerg Med 1993;11:249 250.

127.DeGroff CG, Silka MJ. Bronchospasm after intravenous administration of adenosine in a patient with asthma. J Pediatr 1994;125:822 823.

128.Brubaker S, Long B, Koyfman A. Alternative treatment options for

atrioventricular-nodal-reentry tachycardia: an emergency medicine review.

J Emerg Med 2018;54:198 206.

129.Stambler BS, Dorian P, Sager PT, Wight D, Douville P, Potvin D, Shamszad P, Haberman RJ, Kuk RS, Lakkireddy DR, Teixeira JM, Bilchick KC, Damle RS, Bernstein RC, Lam WW, O’Neill G, Noseworthy PA, Venkatachalam KL, Coutu B, Mondesert B, Plat F. Etripamil nasal spray for rapid conversion of supraventricular tachycardia to sinus rhythm. J Am Coll Cardiol 2018;72:489 497.

130.Olasveengen TM, de Caen AR, Mancini ME, Maconochie IK, Aickin R, Atkins DL, Berg RA, Bingham RM, Brooks SC, Castre´n M, Chung SP, Considine J, Couto TB, Escalante R, Gazmuri RJ, Guerguerian AM, Hatanaka T, Koster RW, Kudenchuk PJ, Lang E, Lim SH, Løfgren B, Meaney PA, Montgomery WH,

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

Morley PT, Morrison LJ, Nation KJ, Ng KC, Nadkarni VM, Nishiyama C, Nuthall G, Ong GY, Perkins GD, Reis AG, Ristagno G, Sakamoto T, Sayre MR, Schexnayder SM, Sierra AF, Singletary EM, Shimizu N, Smyth MA, Stanton D, Tijssen JA, Travers A, Vaillancourt C, Van de Voorde P, Hazinski MF, Nolan JP; ILCOR Collaborators. 2017 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations summary. Circulation 2017;136:e424 e440.

131.Priori SG, Blomstro¨m-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck K- H, Hernandez-Madrid A, Nikolaou N, Norekva˚l TM, Spaulding C, Van Veldhuisen DJ, Kolh P, Lip GYH, Agewall S, Baron-Esquivias G, Boriani G, Budts W, Bueno H, Capodanno D, Carerj S, Crespo-Leiro MG, Czerny M, Deaton C, Dobrev D, Erol C¸, Galderisi M, Gorenek B, Kriebel T, Lambiase P, Lancellotti P, Lane DA, Lang I, Manolis AJ, Morais J, Moreno J, Piepoli MF, Rutten FH, Sredniawa B, Zamorano JL, Zannad F. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 2015;36:2793 2867.

132.Ortiz M, Martin A, Arribas F, Coll-Vinent B, Del Arco C, Peinado R, Almendral J; PROCAMIO Study Investigators. Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study. Eur Heart J 2017;38:1329 1335.

133.Buxton AE, Marchlinski FE, Doherty JU, Flores B, Josephson ME. Hazards of intravenous verapamil for sustained ventricular tachycardia. Am J Cardiol 1987;59:1107 1110.

134.Dancy M, Camm AJ, Ward D. Misdiagnosis of chronic recurrent ventricular tachycardia. Lancet 1985;326:320 323.

135.Crijns HJ, Lie KI. Haemodynamic deterioration after treatment with adenosine. Br Heart J 1995;73:103.

136.Gorgels APM, van den Dool A, Hofs A, Mulleneers R, Smeets JLRM, Vos MA, Wellens HJJ. Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia. Am J Cardiol 1996;78:43 46.

137.Scheinman MM, Levine JH, Cannom DS, Friehling T, Kopelman HA, Chilson DA, Platia EV, Wilber DJ, Kowey PR. Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. Circulation 1995;92:3264 3272.

138.Levine JH, Massumi A, Scheinman MM, Winkle RA, Platia EV, Chilson DA, Gomes JA, Woosley RL. Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. J Am Coll Cardiol 1996;27:67 75.

139.Olshansky B, Sullivan RM. Inappropriate sinus tachycardia. Europace 2019;21:194 207.

140.Still A-M, Raatikainen P, Ylitalo A, Kauma H, Ik€aheimo M, Kes€aniemi YA, Huikuri HV. Prevalence, characteristics and natural course of inappropriate sinus tachycardia. Europace 2005;7:104 112.

141.Baruscotti M, Bucchi A, Milanesi R, Paina M, Barbuti A, Gnecchi-Ruscone T, Bianco E, Vitali-Serdoz L, Cappato R, DiFrancesco D. A gain-of-function mutation in the cardiac pacemaker HCN4 channel increasing cAMP sensitivity is associated with familial Inappropriate Sinus Tachycardia. Eur Heart J 2017;38:280 288.

142.Ruzieh M, Moustafa A, Sabbagh E, Karim MM, Karim S. Challenges in treatment of inappropriate sinus tachycardia. Curr Cardiol Rev 2018;14:42 44.

143.Brunner S, Herbel R, Drobesch C, Peters A, Massberg S, Kaab S, Sinner MF. Alcohol consumption, sinus tachycardia, and cardiac arrhythmias at the Munich Octoberfest: results from the Munich Beer Related Electrocardiogram Workup Study (MunichBREW). Eur Heart J 2017;38:2100 2106.

144.Shen WK. How to manage patients with inappropriate sinus tachycardia. Heart Rhythm 2005;2:1015 1019.

145.Foster MC, Levine PA. Use of verapamil to control an inappropriate chronic sinus tachycardia. Chest 1984;85:697 699.

146.Cappato R, Castelvecchio S, Ricci C, Bianco E, Vitali-Serdoz L, GnecchiRuscone T, Pittalis M, De Ambroggi L, Baruscotti M, Gaeta M, Furlanello F, Di Francesco D, Lupo PP. Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, doubleblind, crossover evaluation. J Am Coll Cardiol 2012;60:1323 1329.

147.Ptaszynski P, Kaczmarek K, Ruta J, Klingenheben T, Wranicz JK. Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy. Europace 2013;15:116 121.

MacIA E. Long-term outcomes of ivabradine in inappropriate sinus tachycardia patients: appropriate efficacy or inappropriate patients. Pacing Clin Electrophysiol 2013;36:830 836.

149.Calo L, Rebecchi M, Sette A, Martino A, de Ruvo E, Sciarra L, De Luca L, Zuccaro LM, Giunta G, Ciccaglioni A, Lioy E, Fedele F. Efficacy of ivabradine

administration in patients affected by inappropriate sinus tachycardia. Heart Rhythm 2010;7:1318 1323.

150.Ptaszynski P, Kaczmarek K, Ruta J, Klingenheben T, Wranicz JK. Ivabradine in the treatment of inappropriate sinus tachycardia in patients after successful radiofrequency catheter ablation of atrioventricular node slow pathway. Pacing Clin Electrophysiol 2013;36:42 49.

151.Dias da Silva VJ, Tobaldini E, Rocchetti M, Wu MA, Malfatto G, Montano N, Zaza A. Modulation of sympathetic activity and heart rate variability by ivabradine. Cardiovasc Res 2015;108:31 38.

152.Ptaszynski P, Kaczmarek K, Ruta J, Klingenheben T, Cygankiewicz I, Wranicz JK. Ivabradine in combination with metoprolol succinate in the treatment of inappropriate sinus tachycardia. J Cardiovasc Pharmacol Ther 2013;18:338 344.

153.Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomstro¨m-Lundqvist C, Cıfkova R, De Bonis M, Iung B, Johnson MR, Kintscher U, Kranke P, Lang IM, Morais J, Pieper PG, Presbitero P, Price S, Rosano GMC, Seeland U, Simoncini T, Swan L, Warnes CA; ESC Scientific Document Group. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 2018:39:3165 3241.

154.Yu J, Zhou Z, Tay-Sontheimer J, Levy RH, Ragueneau-Majlessi I. Risk of clinically relevant pharmacokinetic-based drug-drug interactions with drugs approved by the U.S. Food and Drug Administration between 2013 and 2016. Drug Metab Dispos 2018;46:835 845.

155.Man KC, Knight B, Tse H-F, Pelosi F, Michaud GF, Flemming M, Strickberger SA, Morady F. Radiofrequency catheter ablation of inappropriate sinus tachycardia guided by activation mapping. J Am Coll Cardiol 2000;35:451 457.

156.Marrouche NF, Beheiry S, Tomassoni G, Cole C, Bash D, Dresing T, Saliba W, Abdul-Karim A, Tchou P, Schweikert R, Leonelli F, Natale A. Three-dimensional nonfluoroscopic mapping and ablation of inappropriate sinus tachycardia: procedural strategies and long-term outcome. J Am Coll Cardiol 2002;39:1046 1054.

157.Callans DJ, Ren J-F, Schwartzman D, Gottlieb CD, Chaudhry FA, Marchlinski FE. Narrowing of the superior vena cava right atrium junction during radiofrequency catheter ablation for inappropriate sinus tachycardia: analysis with intracardiac echocardiography. J Am Coll Cardiol 1999;33:1667 1670.

158.Takemoto M, Mukai Y, Inoue S, Matoba T, Nishizaka M, Ide T, Chishaki A, Sunagawa K. Usefulness of non-contact mapping for radiofrequency catheter ablation of inappropriate sinus tachycardia: new procedural strategy and longterm clinical outcome. Intern Med 2012;51:357 362.

159.Koplan BA, Parkash R, Couper G, Stevenson WG. Combined epicardial-endo- cardial approach to ablation of inappropriate sinus tachycardia. J Cardiovasc Electrophysiol 2004;15:237 240.

160.Jacobson JT, Kraus A, Lee R, Goldberger JJ. Epicardial/endocardial sinus node ablation after failed endocardial ablation for the treatment of inappropriate sinus tachycardia. J Cardiovasc Electrophysiol 2014;25:236 241.

161.Rodrıguez-Ma~nero M, Kreidieh B, Al Rifai M, Ibarra-Cortez S, Schurmann P,

Juanatey JR, Valderrabano M. Ablation of inappropriate sinus tachycardia: a systematic review of the literature. JACC Clin Electrophysiol 2017;3:253 265.

162.Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001;344:501 509.

163.Gomes JA, Hariman RJ, Kang PS, Chowdry IH. Sustained symptomatic sinus node reentrant tachycardia: Incidence, clinical significance, electrophysiologic observations and the effects of antiarrhythmic agents. J Am Coll Cardiol 1985;5:45 57.

164.Malik AK, Ching CK, Liew R, Chong DT, Teo WS. Successful ablation of sinus node reentrant tachycardia using remote magnetic navigation system. Europace 2012;14:455 456.

165.Cossu SF, Steinberg JS. Supraventricular tachyarrhythmias involving the sinus node: clinical and electrophysiologic characteristics. Prog Cardiovasc Dis 1998;41:51 63.

166.Sanders WE Jr, Sorrentino RA, Greenfield RA, Shenasa H, Hamer ME, Wharton JM. Catheter ablation of sinoatrial node reentrant tachycardia. J Am Coll Cardiol 1994;23:926 934.

167.Fu Q, VanGundy TB, Shibata S, Auchus RJ, Williams GH, Levine BD. Exercise training versus propranolol in the treatment of the postural orthostatic tachycardia syndrome. Hypertension 2011;58:167 175.

168.Fu Q, VanGundy TB, Galbreath MM, Shibata S, Jain M, Hastings JL, Bhella PS, Levine BD. Cardiac origins of the postural orthostatic tachycardia syndrome. J Am Coll Cardiol 2010;55:2858 2868.

169.Winker R, Barth A, Bidmon D, Ponocny I, Weber M, Mayr O, Robertson D, Diedrich A, Maier R, Pilger A, Haber P, Ru¨diger HW. Endurance exercise training in orthostatic intolerance. A randomized, controlled trial 2005;45: 391 398.

170.Jacob G, Shannon JR, Black B, Biaggioni I, Mosqueda-Garcia R, Robertson RM, Robertson D. Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia. Circulation 1997;96:575 580.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

171.Raj SR, Biaggioni I, Yamhure PC, Black BK, Paranjape SY, Byrne DW, Robertson

D.Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome. Circulation 2005;111:1574 1582.

172.Raj SR, Black BK, Biaggioni I, Paranjape SY, Ramirez M, Dupont WD, Robertson

D.Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome. Less is more. Circulation 2009;120:725 734.

173.Kanjwal K, Karabin B, Sheikh M, Elmer L, Kanjwal Y, Saeed B, Grubb BP. Pyridostigmine in the treatment of postural orthostatic tachycardia: A singlecenter experience. Pacing Clin Electrophysiol 2011;34:750 755.

174.Raj SR, Black BK, Biaggioni I, Harris PA, Robertson D. Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome. Circulation 2005;111:2734 2740.

175.McDonald C, Frith J, Newton JL. Single centre experience of ivabradine in postural orthostatic tachycardia syndrome. Europace 2011;13:427 430.

176.Glukhov AV, Hage LT, Hansen BJ, Pedraza-Toscano A, Vargas-Pinto P, Hamlin RL, Weiss R, Carnes CA, Billman GE, Fedorov VV. Sinoatrial node reentry in a canine chronic left ventricular infarct model: role of intranodal fibrosis and heterogeneity of refractoriness. Circ Arrhythm Electrophysiol 2013;6:984 994.

177.Sheldon RS, Grubb BP, Olshansky B, Shen W-K, Calkins H, Brignole M, Raj SR, Krahn AD, Morillo CA, Stewart JM, Sutton R, Sandroni P, Friday KJ, Hachul DT, Cohen MI, Lau DH, Mayuga KA, Moak JP, Sandhu RK, Kanjwal K. 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm 2015;12:e41 e63.

178.Bryarly M, Phillips LT, Fu Q, Vernino S, Levine BD. Postural orthostatic tachycardia syndrome: JACC Focus Seminar. J Am Coll Cardiol 2019;73:1207 1228.

179.Benarroch EE. Postural tachycardia syndrome: a heterogeneous and multifactorial disorder. Mayo Clinic Proceedings 2012;87:1214 1225.

180.Tomichi Y, Kawano H, Mukaino A, Chiba A, Doi Y, Arakawa S, Ishimatsu T, Fukae S, Abiru N, Maemura K. Postural orthostatic tachycardia in a patient with type 2 diabetes with diabetic neuropathy. Int Heart J 2018;59:1488 1490.

181.Low PA, Sandroni P, Joyner M, Shen WK. Postural tachycardia syndrome (POTS). J Cardiovasc Electrophysiol 2009;20:352 358.

182.Fedorowski A. Postural orthostatic tachycardia syndrome: clinical presentation, aetiology, and management. J Intern Med 2018;285:352 366.

183.Poutiainen AM, Koistinen MJ, Airaksinen KE, Hartikainen EK, Kettunen RVJ, Karjalainen JE, Huikuri HV. Prevalence and natural course of ectopic atrial tachycardia. Eur Heart J 1999;20:694 700.

184.Kistler PM, Sanders P, Fynn SP, Stevenson IH, Hussin A, Vohra JK, Sparks PB, Kalman JM. Electrophysiological and electrocardiographic characteristics of focal atrial tachycardia originating from the pulmonary veins: acute and long-term outcomes of radiofrequency ablation. Circulation 2003;108:1968 1975.

185.Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659 666.

186.Kistler PM, Roberts-Thomson KC, Haqqani HM, Fynn SP, Singarayar S, Vohra JK, Morton JB, Sparks PB, Kalman JM. P-wave morphology in focal atrial tachycardia: development of an algorithm to predict the anatomic site of origin. J Am Coll Cardiol 2006;48:1010 1017.

187.Chen SA, Chiang CE, Yang CJ, Cheng CC, Wu TJ, Wang SP, Chiang BN, Chang MS. Sustained atrial tachycardia in adult patients. Electrophysiological characteristics, pharmacological response, possible mechanisms, and effects of radiofrequency ablation. Circulation 1994;90:1262 1278.

188.Mehta AV, Sanchez GR, Sacks EJ, Casta A, Dunn JM, Donner RM. Ectopic automatic atrial tachycardia in children: clinical characteristics, management and fol- low-up. J Am Coll Cardiol 1988;11:379 385.

189.Hohnloser SH, Zabel M. Shortand long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias. Am J Cardiol 1992;70:A3 A10.

190.Kunze K-P, Kuck K-H, Schlu¨ter M, Bleifeld W. Effect of encainide and flecainide on chronic ectopic atrial tachycardia. J Am Coll Cardiol 1986;7:1121 1126.

191.Eidher U, Freihoff F, Kaltenbrunner W, Steinbach K. Efficacy and safety of ibutilide for the conversion of monomorphic atrial tachycardia. Pacing Clin Electrophysiol 2006;29:358 362.

192.Vietti-Ramus G, Veglio F, Marchisio U, Burzio P, Latini R. Efficacy and safety of short intravenous amiodarone in supraventricular tachyarrhythmias. Int J Cardiol 1992;35:77 85.

193.Salem JE, Dureau P, Funck-Brentano C, Hulot JS, El-Aissaoui M, Aissaoui N, Urien S, Faisy C. Effectiveness of heart rate control on hemodynamics in critically ill patients with atrial tachyarrhythmias managed by amiodarone. Pharmacol Res 2017;122:118 126.

194.Anguera I, Brugada J, Roba M, Mont Ls, Aguinaga L, Geelen P, Brugada P. Outcomes after radiofrequency catheter ablation of atrial tachycardia. Am J Cardiol 2001;87:886 890.

195.Biviano AB, Bain W, Whang W, Leitner J, Dizon J, Hickey K, Garan H. Focal left atrial tachycardias not associated with prior catheter ablation for atrial